phenytoin has been researched along with Glycogen Storage Disease in 3 studies
Glycogen Storage Disease: A group of inherited metabolic disorders involving the enzymes responsible for the synthesis and degradation of glycogen. In some patients, prominent liver involvement is presented. In others, more generalized storage of glycogen occurs, sometimes with prominent cardiac involvement.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Walson, P | 1 |
| Trinca, C | 1 |
| Bressler, R | 1 |
| Brown, BI | 1 |
| Jubiz, W | 1 |
| Rallison, ML | 1 |
3 other studies available for phenytoin and Glycogen Storage Disease
| Article | Year |
|---|---|
New uses for phenytoin.
Topics: Arrhythmias, Cardiac; Diabetic Neuropathies; Digitalis Glycosides; Drug Evaluation; Epilepsy; Gastro | 1975 |
Diphenylhydantoin treatment.
Topics: Glycogen Storage Disease; Humans; Phenytoin | 1975 |
Diphenylhydantoin treatment of glycogen storage diseases.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Glucose-6-Phosphatase; Glucosidases; Glucosyltra | 1974 |